Efficacy of Benidipine Hydrochloride on Cardiac Event in Patients with Vasospastic Angina without Significant Coronary Artery Narrowing: Comparison with Diltiazem by Case Control Study

Therapeutic Research

Volumn 24, Issue 11, 2003, Pages 2093-2100

  Sakata, Kazuyuki ^a   Kudo, Masahiro ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Acetylcholine; Benidipine hydrochloride; Calcium antagonist; Coronary spasm; Diltiazem hydrochloride; Vasospastic angina

Indexed keywords

BENIDIPINE; DILTIAZEM;

ACUTE HEART INFARCTION; ANGINA PECTORIS; ARTICLE; BODY MASS; CORONARY ARTERY OBSTRUCTION; DRUG EFFICACY; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; RIGHT CORONARY ARTERY; VASOSPASM;

EID: 0347993803     PISSN: 02898020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Shimokawa H, et al. Clinical characteristics and long-term prognosis of patients with variant angina: a comparative study between western and Japanese populations. Int J Cardiol 1988;18:331-49.
2. Pristipino C, et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 2000;101:1102-8.
3. Yasue H. Coronary artery spasm. Tokyo:Axel Springer Japan Publishing; 2000. p.12.
4. Yasue H, et al. Long-term prognosis for patients with variant angina. Circulation 1988;78:1-9.
5. Kimura E, Kishida H. Treatment of variant angina with drugs: a survey of 11 cardiology institutes in Japan. Circulation 1981;63:844-8.
6. Morikami Y, Yasue H. Efficacy of slow-release nifedipine on myocardial ischemic episodes in variant angina pectoris. Am J Cardiol 1991;68:580-4.
7. Karasawa A, Kubo K. Calcium antagonistic effects and the in vitro duration of actions of KW-3049, a new 1,4-dihydropyridine derivative, in isolated canine coronary arteries. Jpn J Pharmacol 1988;47:35-44.
8. Moriyama T, Karasawa A. Cardiovascular effects of benidipine and amlodipine in isolated tissues and anesthetized dogs. Biol Pharm Bull 1994;17:1468-71.
9. Shimada S, et al. Comparative pharmacodynamics of eight calcium channel blocking agents in Japanese essential hypertensive patients. Biol Pharm Bull 1996;19:430-7.
10. 3H]benidipine hydrochloride to rat heart membranes. J Cardiovasc Pharmacol 1993;21:191-6.
11. Pepine CJ, et al. Effect of diltiazem in patients with variant angina: a randomized double-blind trial. Am Heart J 1981;101:719-25.
12. Tilmant PY, et al. Detrimental effect of propranolol in patients with coronary arterial spasm countered by combination with diltiazem. Am J Cardiol 1983;52: 230-3.
13. Sakata K, et al. Assessment of quantitative exercise thallium-201 emission computed tomography in patients with vasospastic angina: value of washout rate analysis. Jpn Circ J 1994;58:379-88.
14. Sundararajan V, et al. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med 2002;136:349-57.
15. Elad Y, et al. Primary angioplasty and selection bias inpatients presenting late (> 12 h) after onset of chest pain and ST elevation myocardial infarction. J Am Coll Cardiol 2002;39:826-33.
16. Prinzmetal M, et al. Angina pectoris: I. The variant form of angina pectoris. Am J Med 1959;27:375.
17. Dhurandhar RW, et al. Prinzmetal's variant form of angina with arteriographic evidence of coronary arterial spasm. Am J Cardiol 1972;30:902-5.
18. Mongiardo R, et al. Low incidence of serotonin-induced occlusive coronary artery spasm in patients with recent myocardial infarction. Am J Cardiol 1996;78:84-7.
19. Okumura K, et al. Effect of acetylcholine on the highly stenotic coronary artery: difference between the constrictor response of the infarct-related artery. J Am Coll Cardiol 1992;19:752-8.
20. Nakamura M, Takeshita A, Nose Y. Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden cardiac death in patients with vasospastic angina. Circulation 1987;75:1110-16.
21. Karasawa A, et al. Pharmacological actions of benidipine hydrochloride in several isolated smooth muscles and myocardium. Arzneimittelforschung 1988;38(11A):1722-30.
22. Karasawa A, et al. Antianginal effects of the new calcium antagonist benidipine hydrochloride in anesthetized rats and spontaneously hypertensive rats. Electrocardiographic study. Arzneimittelforschung 1988;38(11A):1702-7.
23. Suzuki H, et al. Histological evaluation of coronary plaque in patients with variant angina: relationship between vasospasm and neointimal hyperplasia in primary coronary lesions. J Am Coll Cardiol 1999;33: 198-205.
24. Yasue H, et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 1986;74:955-63.
25. Kugiyama K, et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 1996;94:266-72.
26. Okumura K, et al. Endothelium-dependent dilator response to substance P in patients with coronary spastic angina. J Am Coll Cardiol 1992;20:838-44.
27. 786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999;99:2864-70.
28. Kobayashi N, et al. Benidipine stimulates nitric oxide synthase and improves coronary circulation in hypertensive rats. Am J Hypertens 1999;12:483-91.
29. Kitakaze M, et al. A Ca channel blocker, benidipine, increases coronary blood flow and attenuates the severity of myocardial ischemia via NO-dependent mechanisms in dogs. J Am Coll Cardiol 1999;33:242-9.
30. Ther Res 2002;23:2065-9.
31. Takase H, et al. Long-term effect of antihypertensive therapy with calcium antagonist or angiotensin converting enzyme inhibitor on serum nitrite/nitrate levels in human essential hypertension. Arzneimittelforschung 2000;50:530-4.
32. Sueda S, et al. Limitations of medical therapy in patients with pure coronary spastic angina. Chest 2003;123:380-6.